Mankind Pharma Ltd., India’s 4th largest pharmaceutical company, today announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor. The molecule is being developed
- New Centre to Drive Green Technologies in Drug Product ManufacturingGranules India Limited, in partnership with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, today inaugurated the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).This Granules’ CSR
Built to global quality and sustainability standards, Iberia’s facility is a key unit under ‘Make-In-India’ movementThe company has invested around 70 crores in this world class manufacturing and research facilityIberia Pharmaceuticals, a leading name in skincare, is proud to announce its new hi-tech manufacturing and
Representation also sent to the Central Drugs Standard Control Organization Urgent appeal to ban nicotine pouches and gums – the next new-age gateway threat Licensed pharmaceutical companies used as a front to sell nicotine pouches in India MNC Tobacco Companies are allegedly commissioning research
The Institute of Health Management Research (IIHMR), Bangalore, marked a proud milestone with the celebration of its 14th Convocation Ceremony at its Electronic City campus, honouring the graduating PGDM batch of 2023–25 (AICTE Approved). The event showcased the institute’s enduring commitment to shaping visionary leaders in hospital management, health IT,
40 women from tier two and three institutions selected for the third cohort of the program Over 50 women benefitted from the successful conclusion of the first and second cohortSyngene International Ltd., an integrated research, development, and manufacturing services organization, in partnership with
Rising Alarms Over Substandard Drugs NITI Aayog has initiated a review following alarming data from the Central Drugs Standard Control Organisation (CDSCO), which revealed that multiple micro, small, and medium enterprise (MSME) pharmaceutical firms in India are producing substandard medications, prompting calls for strengthened oversight and
Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven global pharmaceutical company, has joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative. With this strategic move, the company aligns its operations and strategies with the UNGC’s Ten Principles on human rights, labour,
n a landmark development for global cancer care, Cipla Limited (BSE: 500087; NSE: CIPLA EQ), a leading global pharmaceutical company, today announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for
Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss- based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. This marks a strategic milestone in Granules’ transformation into a science-
